These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24666998)

  • 1. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma.
    Johnson ME; Zhu F; Li T; Wu H; Galloway TJ; Farma JM; Perlis CS; Turaka A
    J Am Acad Dermatol; 2014 Jun; 70(6):1028-35. PubMed ID: 24666998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high neutrophil-to-lymphocyte ratio as a potential marker of mortality in patients with Merkel cell carcinoma: A retrospective study.
    Zaragoza J; Kervarrec T; Touzé A; Avenel-Audran M; Beneton N; Esteve E; Wierzbicka Hainaut E; Aubin F; Machet L; Samimi M
    J Am Acad Dermatol; 2016 Oct; 75(4):712-721.e1. PubMed ID: 27544490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
    Smith VA; Camp ER; Lentsch EJ
    Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
    Smith VA; MaDan OP; Lentsch EJ
    Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ transplant recipients with Merkel cell carcinoma have reduced progression-free, overall, and disease-specific survival independent of stage at presentation.
    Arron ST; Canavan T; Yu SS
    J Am Acad Dermatol; 2014 Oct; 71(4):684-90. PubMed ID: 24993599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease.
    Foote M; Veness M; Zarate D; Poulsen M
    J Am Acad Dermatol; 2012 Sep; 67(3):395-9. PubMed ID: 22030017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
    Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Role of Tumoral PD-L1 and IDO1 Expression, and Intratumoral CD8+ and FoxP3+ Lymphocyte Infiltrates in 132 Primary Cutaneous Merkel Cell Carcinomas.
    Donizy P; Wu CL; Kopczynski J; Pieniazek M; Biecek P; Ryś J; Hoang MP
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merkel cell carcinomas infiltrated with CD33
    Kervarrec T; Gaboriaud P; Berthon P; Zaragoza J; Schrama D; Houben R; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Domenech J; Guyétant S; Touzé A; Samimi M
    J Am Acad Dermatol; 2018 May; 78(5):973-982.e8. PubMed ID: 29273486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival?
    Sandel HD; Day T; Richardson MS; Scarlett M; Gutman KA
    Laryngoscope; 2006 May; 116(5):791-5. PubMed ID: 16652089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.
    Oki Y; Yamamoto K; Kato H; Kuwatsuka Y; Taji H; Kagami Y; Morishima Y
    Eur J Haematol; 2008 Dec; 81(6):448-53. PubMed ID: 18691256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel node status and immunosuppression: recurrence factors in localized Merkel cell carcinoma.
    Jouary T; Kubica E; Dalle S; Pages C; Duval-Modeste AB; Guillot B; Mansard S; Saiag P; Aubin F; Bedane C; Dalac S; Dompmartin A; Granel-Brocard F; Lok C; Stoebner PE; Lacour JP; Leccia MT; Diallo A; Ezzedine K; Mateus C
    Acta Derm Venereol; 2015 Sep; 95(7):835-40. PubMed ID: 25784178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merkel cell carcinoma of the skin: a retrospective study of 24 cases by the Hellenic Cooperative Oncology Group.
    Pectasides D; Papaxoinis G; Pectasides E; Galani H; Razi E; Katodrytis N; Fountzilas G; Economopoulos T
    Oncology; 2007; 72(3-4):211-8. PubMed ID: 18176086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A better prognosis for Merkel cell carcinoma of unknown primary origin.
    Chen KT; Papavasiliou P; Edwards K; Zhu F; Perlis C; Wu H; Turaka A; Berger A; Farma JM
    Am J Surg; 2013 Nov; 206(5):752-7. PubMed ID: 23835211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course and prognostic factors of Merkel cell carcinoma of the skin.
    Güler-Nizam E; Leiter U; Metzler G; Breuninger H; Garbe C; Eigentler TK
    Br J Dermatol; 2009 Jul; 161(1):90-4. PubMed ID: 19438439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.
    Paulson KG; Iyer JG; Tegeder AR; Thibodeau R; Schelter J; Koba S; Schrama D; Simonson WT; Lemos BD; Byrd DR; Koelle DM; Galloway DA; Leonard JH; Madeleine MM; Argenyi ZB; Disis ML; Becker JC; Cleary MA; Nghiem P
    J Clin Oncol; 2011 Apr; 29(12):1539-46. PubMed ID: 21422430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant local irradiation for Merkel cell carcinoma.
    Lewis KG; Weinstock MA; Weaver AL; Otley CC
    Arch Dermatol; 2006 Jun; 142(6):693-700. PubMed ID: 16785371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia.
    Sun D; Elson P; Liedtke M; Medeiros BC; Earl M; Alizadeh A; Bates J; Sekeres MA; Coutre S; Kalaycio M; Sobecks R; Copelan E; Advani AS
    Am J Hematol; 2012 Oct; 87(10):957-60. PubMed ID: 22729847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
    Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
    J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.
    Porrata LF; Ristow K; Habermann TM; Witzig TE; Inwards DJ; Markovic SN
    Am J Hematol; 2009 Feb; 84(2):93-7. PubMed ID: 19123458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.